Provision of knee bracing for knee osteoarthritis (PROP OA): multicentre, parallel group, superiority, statistician blinded, randomised controlled trial.

Melanie A Holden, Elaine Nicholls, Zainab Abdali, Fraser Birrell, Belinda Borrelli, Michael Callaghan, Krysia Dziedzic, David Felson, Nadine E Foster, Nicola Halliday, Carol Ingram, Clare Jinks, Sue Jowett, George Peat

Journal: BMJ (Clinical research ed.) 2026;392():e086005

PMID: 41587822

Abstract

OBJECTIVE

To determine whether adding compartment specific knee bracing with an adherence intervention to advice, written information, and exercise instruction (AIE+B) is superior to advice, written information, and exercise instruction (AIE) only in improving patient reported outcomes in people with knee osteoarthritis.

DESIGN

Multicentre, parallel group, superiority, statistician blinded, randomised (1:1; block; stratified; centralised web based) controlled trial.

SETTING

Recruitment through general practices and the community in Cheshire, Manchester, North Tyneside, and Staffordshire, England; enrolment 25 November 2019 to 16 September 2022.

PARTICIPANTS

466 adults aged ≥45 years with symptoms of knee osteoarthritis.

INTERVENTIONS

AIE was delivered in one in-person consultation by a trained physiotherapist. Individuals randomised to the AIE+B group were also fitted with a patellofemoral, tibiofemoral unloading, or neutral stabilising knee brace, according to their predominant compartmental distribution of knee osteoarthritis, and were offered a two week follow-up consultation. Brief motivational interviewing with targeted text reminders supported brace adherence.

MAIN OUTCOME MEASURES

The primary outcome was a composite patient reported Knee Osteoarthritis Outcomes Score (KOOS)-5 (0-100) at six months after randomisation. Key secondary outcomes were KOOS-5 at three and 12 months, KOOS-5 subscale scores, and pain on weight bearing activity at three, six, and 12 months.

RESULTS

466 participants (mean age 64 (standard deviation 9) years; 46% female participants) were randomised, with 401 (86%), 394 (85%), and 370 (79%) participants followed up with analysable data at three, six, and 12 months, respectively. At six months, greater improvement in KOOS-5 was seen in the AIE+B group than in the AIE group (adjusted mean difference 3.39, 95% confidence interval (CI) 0.96 to 5.82; effect size 0.24). Secondary outcomes showed the benefits of AIE+B over AIE that diminished over time. The largest effects observed were for pain reduction (KOOS pain (0-100) adjusted mean difference at six months 6.13, 95% CI 3.36 to 8.91; effect size 0.39). Adverse events were minor and expected.

CONCLUSIONS

Adding compartment specific knee bracing and an adherence intervention to advice, written information, and exercise instruction resulted in small improvements in patient reported outcomes among individuals with knee osteoarthritis. This safe intervention offers a potential treatment option for this common condition.

TRIAL REGISTRATION

ISRCTN28555470.

© Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY. No commercial re-use. See rights and permissions. Published by BMJ.

Address: School of Medicine, Primary Care Centre Arthritis UK, Keele University, Keele ST5 5BG, UK.; School of Medicine, Primary Care Centre Arthritis UK, Keele University, Keele ST5 5BG, UK.; Keele Clinical Trials Unit, Keele University, Keele, UK.; Health Economics Unit, Department of Applied Health Sciences, University of Birmingham, Birmingham, UK.; Medical Research Council Versus Arthritis Centre for Integrated Research into Musculoskeletal Ageing, Population, and Health Sciences Institute, Newcastle University, Newcastle upon Tyne, UK.; Northumbria Healthcare NHS Foundation Trust, North Shields, UK.; Faculty of Biology, Medicine, and Health, University of Manchester, Manchester, UK.; Henry M Goldman School of Dental Medicine, Boston University, Boston, MA, USA.; School of Health Sciences, Division of Psychology and Mental Health, Manchester Centre for Health Psychology and Manchester Academic Health Science Centre, University of Manchester, Manchester, UK.; Faculty of Health and Education, Manchester Metropolitan University, Manchester, UK.; NIHR Manchester Biomedical Research Centre, Manchester University Foundation NHS Trust, Manchester, UK.; School of Medicine, Primary Care Centre Arthritis UK, Keele University, Keele ST5 5BG, UK.; Impact Accelerator Unit, Keele University, Keele, UK.; Research in OsteoArthritis Manchester (ROAM), Centre for Epidemiology Versus Arthritis, Centre for Musculoskeletal Research, Institute of Inflammation and Repair, University of Manchester, Manchester, UK.; School of Medicine, Boston University, Boston, MA, USA.; STARS Education and Research Alliance, Surgical Treatment and Rehabilitation Service, University of Queensland and Metro North Health, Brisbane, QLD, Australia.; Keele Clinical Trials Unit, Keele University, Keele, UK.; Public representative, Research User Group, Primary Care Centre Arthritis UK, School of Medicine, Keele University, Keele, UK.; School of Medicine, Primary Care Centre Arthritis UK, Keele University, Keele ST5 5BG, UK.; Centre for Applied Health and Social Care Research (CARe), School of Health and Social Care, Sheffield Hallam University, Sheffield, UK.

Link outs

Subscription / membership required

Bant logo

© Copyright 2026, Nutrition Evidence

NED wishes to thank the following organisations for their support:

We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.